Showing 19 of 59 recruiting trials for “hereditary-clear-cell-renal-cell-carcinoma”
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
👨⚕️ Brian I Rini, MD, Vanderbilt University/Ingram Cancer Center📍 6 sites📅 Started Dec 2022View details ↗
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
RecruitingNCT06088134 ↗
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
👨⚕️ Weijia Fang, M.D, The First Affiliated Hospital, Zhejiang University📍 1 site📅 Started May 2022View details ↗
RecruitingNCT05287464 ↗
International Multicentric Study ARON-1
RecruitingNCT05363657 ↗
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
👨⚕️ Andrea Minervini, Prof., Dipartimento di Medicina Clinica e Sperimentale Via o Piazza Largo Brambilla 3 - 50134 Firenze (Italy)📍 37 sites📅 Started Jan 2022View details ↗
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
RecruitingNCT05248412 ↗
The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingNCT04712305 ↗
Urine Omics Predicting IO Therapy Responses in mRCC Patients
RecruitingNCT03987633 ↗
EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
👨⚕️ Vitaly Margulis, MD, University of Texas Southwestern Medical Center📍 1 site📅 Started Sep 2019View details ↗
RecruitingNCT03702309 ↗
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
RecruitingNCT04792463 ↗
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
RecruitingNCT02012699 ↗
Integrated Cancer Repository for Cancer Research
RecruitingNCT06147349 ↗
Kidney Cancer Observational Protocol
RecruitingNCT00050752 ↗
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
👨⚕️ W. Marston Linehan, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Feb 2003View details ↗
← PreviousPage 3 of 3
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →